Prospects for Obesity Medicines

The recent launches of two highly effective obesity medicines – Wegovy & Mounjaro - have been hugely commercially successful & culturally influential.  Despite these deserved accolades, this presentation will argue these two medicines are likely to have a negligible impact on population mortality.

The presentation will also argue a future wave of potential new obesity medicines could collectively overcome the drawbacks of Wegovy & Mounjaro.  In turn, this future wave could create the potential for a positive impact on future population mortality.